Akiko Tenma

Title: Akiko Tenma: Innovator in Immunogenic Vaccine Development

Introduction

Akiko Tenma is a prominent inventor based in Suita, Japan, known for her significant contributions to the field of immunogenic vaccine development. With a total of 10 patents to her name, she has made remarkable strides in creating innovative solutions for disease prevention.

Latest Patents

Among her latest patents is a conjugate vaccine targeting a disease-causing biological protein. This invention provides a vaccine that contains a complex of a peptide consisting of the amino acid sequence of SEQ ID NO: 1 and an epitope of a disease-causing biological protein such as DPP4, IL-17A, IgE, S100A9, or PCSK9. The vaccine utilizes a less antigenic carrier protein and is capable of inducing antibody production, serving as an effective vaccine. Another notable patent is an immunogenic composition targeting S100A9. This composition comprises an antigenic peptide capable of inducing the production of a neutralizing antibody against S100A9 and a carrier protein. It is designed to be a highly safe antithrombotic vaccine, providing an antithrombotic effect without a long-term bleeding risk, particularly useful for preventing recurrent ischemic strokes.

Career Highlights

Akiko Tenma has worked with esteemed institutions such as Osaka University and Funpep Co., Ltd. Her work has been pivotal in advancing vaccine technology and improving public health outcomes.

Collaborations

She has collaborated with notable colleagues, including Ryuichi Morishita and Hironori Nakagami, contributing to her innovative research and development efforts.

Conclusion

Akiko Tenma's work in immunogenic vaccine development showcases her dedication to advancing medical science and improving health outcomes. Her innovative patents reflect her commitment to addressing critical health challenges through research and collaboration.